RxDoctor Payments Data

Prasanna Muniyappa, MD

Internal Medicine · Marysville, OHNPI 1689667594

Payments from drug & device makers

$738in general payments, 2019–2025

Across 67 payments — averaging $11.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$350
  • Biohaven Pharmaceuticals, Inc.$111
  • Boston Scientific$90
  • Astellas Pharma US Inc$59
  • AstraZeneca$45
  • Amarin Pharma, Inc.$40
  • plus $44 from 2 others

What the payments were for

  • Food & beverage$738100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$738 in reported general payments places this provider in the 70th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$63,026
Medicare patients
224
Services billed
1,514

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban131$107,020
IngrezzaValbenazine Tosylate21$86,081
OzempicSemaglutide52$68,714
JanuviaSitagliptin Phosphate118$68,385
XareltoRivaroxaban26$41,956
JardianceEmpagliflozin30$32,423
FarxigaDapagliflozin Propanediol28$30,667
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$30,339
RybelsusSemaglutide19$25,769
TrulicityDulaglutide16$15,029
ShingrixVaricella-Zoster Ge/As01b/Pf61$13,201
Breo ElliptaFluticasone/Vilanterol19$9,296
MyrbetriqMirabegron25$8,050
Lantus SolostarInsulin Glargine,hum.Rec.Anlog59$8,041
AbrysvoRsv Vacc, Pref A And Pref B/Pf25$7,909

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$15$114,928156 claims
Novo NordiskOzempic, Rybelsus$350$94,48371 claims
MerckJanuvia$29$68,385118 claims
AstraZenecaFarxiga$45$30,66728 claims
Astellas Pharma US IncMyrbetriq$59$8,05025 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Marysville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →